Stacked
LongevityResearch profile

Thymosin Alpha-1

TA1 · Tα1 · Zadaxin · Thymalfasin

Think of it as a personal trainer for your immune system.

Thymosin Alpha-1 is like having a personal trainer for your immune system, coaching it to perform at its best. It nudges your body's defense team—those hardworking immune cells—to step up their game, making them more effective at their jobs. This can be especially valuable in situations where the immune system might need a little extra help, such as during illness or in response to vaccines.

While it's not a household name in the U.S., many countries use it to help boost immune responses in patients with chronic infections or those undergoing cancer treatments. Think of it as the pep talk your immune system might need to tackle tough challenges.

Although it's not approved in the U.S., Thymosin Alpha-1 has a track record elsewhere for supporting the body's natural defenses when they need a little extra encouragement.

Who it's for

  • People with a keen interest in supporting their immune health.
  • Individuals curious about international approaches to immune boosting.
  • Biohackers exploring longevity and immune resilience.

Probably not for you if…

  • Those looking for FDA-approved treatments in the U.S.
  • People who prefer to rely solely on traditional immune health methods.

Editorial summary for research context · Not medical advice

Mechanism of Action

Thymosin Alpha-1 is a synthetic 28-amino-acid peptide identical to the endogenous thymic hormone. Research suggests it signals via Toll-like receptors (notably TLR-9 and TLR-2) on dendritic cells, modulates Th1/Th2 balance, enhances IL-2 and IFN-gamma production, and supports the maturation of CD4+ and CD8+ T cells. It is approved under the trade name Zadaxin (thymalfasin) in Italy and more than 35 other countries outside the United States as adjuvant therapy for chronic hepatitis B and C, as an immune adjuvant for influenza vaccination in immunocompromised patients, and as adjunctive therapy in certain cancers. It is not FDA-approved for any indication in the US.

Researched Benefits

Immune function in immunocompromised settings

Multiple international clinical trials have evaluated it as adjuvant therapy for chronic hepatitis B and C, with approved indications in Italy and other countries outside the US.

  • [Garaci et al. 2012]
  • [Camerini & Garaci 2015]

Vaccine adjuvancy

Clinical research in hemodialysis and elderly cohorts suggests improved seroconversion rates to influenza and HBV vaccines when co-administered.

  • [Gravenstein et al. 1989]

Oncology adjunctive research

Used in approved adjunctive protocols in several countries for melanoma and non-small-cell lung cancer; research explores T-cell reconstitution during chemotherapy.

  • [King & Tuthill 2016]

Research Protocols

The following dosing ranges have appeared in published research protocols. Presented for informational purposes only — not a recommendation for human use.

General immune research

Dosage
1.6 mg
Frequency
twice weekly
Timing
any time
Cycle
12 weeks

Approved Zadaxin dosing for HBV/HCV indications is 1.6 mg subcutaneously twice weekly. Research protocols often mirror this schedule.

Loading protocol

Dosage
1.6 mg
Frequency
daily
Timing
morning
Cycle
2 weeks

Short daily loading used in acute immune challenge research before transitioning to maintenance dosing.

Reported Side Effects

  • Injection-site erythema and discomfort
  • Transient fatigue or flu-like symptoms on initiation
  • Rare elevation in liver enzymes in hepatitis cohorts

Contraindications

  • Known hypersensitivity to the peptide
  • Active autoimmune disease (relative contraindication given immune-activating profile)
  • Organ transplant recipients on immunosuppression
  • Pregnancy and lactation (limited safety data)

Stacking Partners

Peptides commonly paired with Thymosin Alpha-1 in published research and protocol write-ups.

Vendor Pricing

Stacked earns a commission on purchases via these links. It does not influence our Trust Scores.

Gear + Companions

Reconstitution supplies and research-backed supplement companions for Thymosin Alpha-1. Editorial picks only — we earn a commission through Amazon on the click, no sponsorship.

Gear you'll need

· Reconstitution + storage essentials
  • Bacteriostatic Water 30mL (0.9% Benzyl Alcohol)

    Empower Pharmacy / generic medical supply

    Reconstitutes every lyophilized peptide. 28-day viability refrigerated.

  • Insulin Syringes 31G × 5/16" × 0.5mL (100 count)

    EasyTouch

    31G × 0.5mL insulin syringes — the default size for sub-0.25mL peptide doses.

  • Alcohol Prep Pads (Sterile, 200 count)

    Dynarex

    Sterile 70% IPA prep pads — one per vial stopper + one per injection site.

  • 1-Quart Sharps Disposal Container

    BD / Becton Dickinson

    FDA-cleared sharps container — pharmacies won't accept improvised disposal.

As an Amazon Associate we earn from qualifying purchases · Disclosed per FTC guidelines

Top Videos

Curated from YouTube — refreshed weekly. Stacked doesn't host or endorse external content.

Research Papers

  • Historical review on the discovery, development, and clinical applications of thymosin alpha 1

    Garaci E, Pica F, Serafino A, et al. · Expert Opinion on Biological Therapy · 2012

    PubMed 22400904
  • Thymosin alpha-1: an endogenous regulator of inflammation, immunity, and tolerance

    Romani L, Bistoni F, Puccetti P · Annals of the New York Academy of Sciences · 2007

    PubMed 17554044
  • Thymosin alpha 1 in cancer therapy: immune regulation and combination rationale

    King R, Tuthill C · International Immunopharmacology · 2016

    PubMed 27450047